ACAD Competitors
ACADIA Pharmaceuticals Inc.
$19.71
+$0.46(+2.39%)
50
Overall
75
Value
9
Tech
68
Quality
Market Cap
$3.32B
Volume
1.77M
52W Range
$19.32 - $30.96
Target Price
$32.10
ACAD competitors: VNDA, BMY, PFE, JNJ, LLY. ACADIA Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ACAD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals Inc. | $4.24 | $255.15M | $-3.02 | - | 37 |
| BMY Bristol-Myers Squibb Company | $60.95 | $121.09B | $6.80 | 3.10% | 63 |
| PFE Pfizer Inc. | $29.56 | $166.49B | $2.96 | 5.82% | 70 |
| JNJ Johnson & Johnson | $253.72 | $611.90B | $11.09 | 2.08% | 56 |
| LLY Eli Lilly and Company | $1251.61 | $1.14T | $36.19 | 0.53% | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $19.71 | +2.4% | 1.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW